Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs

Molecular Therapy - Oncolytics - Tập 18 - Trang 1-13 - 2020
Yusuo Tong1, Lili Yang2, Changhua Yu1, Weiguo Zhu1, Xilei Zhou1, Yaozu Xiong1, Wanwei Wang1, Fuzhi Ji1, Dongcheng He1, Xiufeng Cao2,3
1Department of Radiation Oncology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, China
2Department of Oncology Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
3Department of Thoracic Surgery, Taikang Xianlin Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, China

Tài liệu tham khảo

Wu, 2017, Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2, Mol. Cancer, 16, 150, 10.1186/s12943-017-0715-7 Kang, 2018, Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA, J. Exp. Clin. Cancer Res., 37, 171, 10.1186/s13046-018-0845-9 Zhao, 2010, Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?, Int. J. Radiat. Oncol. Biol. Phys., 76, 446, 10.1016/j.ijrobp.2009.02.078 Honing, 2014, A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients, Ann. Oncol., 25, 638, 10.1093/annonc/mdt589 Hamano, 2011, Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway, Clin. Cancer Res., 17, 3029, 10.1158/1078-0432.CCR-10-2532 New, 2017, Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target, Cancer Res., 77, 6679, 10.1158/0008-5472.CAN-17-1077 Li, 2018, Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p, EBioMedicine, 36, 209, 10.1016/j.ebiom.2018.09.006 Quante, 2011, Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth, Cancer Cell, 19, 257, 10.1016/j.ccr.2011.01.020 Kato, 2018, Cancer-associated fibroblasts affect intratumoral CD8+ and FoxP3+ T cells via IL6 in the tumor microenvironment, Clin. Cancer Res., 24, 4820, 10.1158/1078-0432.CCR-18-0205 Grugan, 2010, Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion, Proc. Natl. Acad. Sci. USA, 107, 11026, 10.1073/pnas.0914295107 Kashima, 2019, Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma, Int. J. Cancer, 144, 828, 10.1002/ijc.31953 Ringuette Goulet, 2018, Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGFβ signaling, Mol. Cancer Res., 16, 1196, 10.1158/1541-7786.MCR-17-0784 Kinoshita, 2012, Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma, Br. J. Cancer, 107, 988, 10.1038/bjc.2012.354 Ren, 2018, Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19, Theranostics, 8, 3932, 10.7150/thno.25541 Li, 2019, Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis, Mol. Cancer, 18, 18, 10.1186/s12943-019-0948-8 Singh, 2014, Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer, Mol. Cancer, 13, 256, 10.1186/1476-4598-13-256 Fang, 2018, Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer, Nat. Commun., 9, 191, 10.1038/s41467-017-02583-0 Xu, 2017, Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma, Oncogene, 36, 1965, 10.1038/onc.2016.356 Zhang, 2017, H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma, Nucleic Acids Res., 45, 3086, 10.1093/nar/gkw1247 Lin, 2018, Functional role of a novel long noncoding RNA TTN-AS1 in esophageal squamous cell carcinoma progression and metastasis, Clin. Cancer Res., 24, 486, 10.1158/1078-0432.CCR-17-1851 Zhang, 2019, lncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2, Acta Biochim. Biophys. Sin. (Shanghai), 51, 826, 10.1093/abbs/gmz069 Sun, 2018, Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment, Mol. Cancer, 17, 82, 10.1186/s12943-018-0831-z Zhou, 2016, High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy, Mol. Carcinog., 55, 2095, 10.1002/mc.22454 Liang, 2018, lncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein, Cell Death Differ., 25, 1980, 10.1038/s41418-018-0084-9 Zhang, 2019, Cancer-associated fibroblast-promoted lncRNA DNM3OS confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma, Clin. Cancer Res., 25, 1989, 10.1158/1078-0432.CCR-18-0773 Li, 2019, Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma, Mol. Cancer, 18, 22, 10.1186/s12943-019-0949-7 Yang, 2014, Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells, Gut, 63, 881, 10.1136/gutjnl-2013-305266 Chen, 2019, Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation, Ther. Adv. Med. Oncol., 11, 10.1177/1758835919838958 Li, 2018, Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma, Cancer Lett., 430, 57, 10.1016/j.canlet.2018.05.013 Huang, 2019, Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma, Cell Death Dis., 10, 513, 10.1038/s41419-019-1745-4 Li, 2014, Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells, Gastroenterology, 146 Tong, 2015, Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma, Mol. Cancer, 14, 3, 10.1186/1476-4598-14-3 Wang, 2017, Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9, J. Exp. Clin. Cancer Res., 36, 182, 10.1186/s13046-017-0658-2 Zhou, 2018, Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway, J. Exp. Clin. Cancer Res., 37, 242, 10.1186/s13046-018-0911-3 Zhou, 2018, Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts, J. Exp. Clin. Cancer Res., 37, 324, 10.1186/s13046-018-0965-2 Shan, 2016, Knockdown of linc-POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancer, Oncotarget, 7, 961, 10.18632/oncotarget.5830 Guo, 2015, Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma, Gene, 554, 114, 10.1016/j.gene.2014.10.038 Nagura, 2015, Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta, Gynecol. Oncol., 136, 104, 10.1016/j.ygyno.2014.11.075 Hu, 2019, CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer, Mol. Cancer, 18, 91, 10.1186/s12943-019-1019-x Karakasheva, 2018, IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment, Cancer Res., 78, 4957, 10.1158/0008-5472.CAN-17-2268 Wen, 2019, Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling, Cancer Lett., 442, 320, 10.1016/j.canlet.2018.10.015 Qin, 2019, Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5, Genome Biol., 20, 12, 10.1186/s13059-018-1604-0 Allaoui, 2016, Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers, Nat. Commun., 7, 13050, 10.1038/ncomms13050 Togo, 2013, Carcinoma-associated fibroblasts are a promising therapeutic target, Cancers (Basel), 5, 149, 10.3390/cancers5010149 Yeung, 2013, TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment, Cancer Res., 73, 5016, 10.1158/0008-5472.CAN-13-0023 Kalluri, 2016, The biology and function of fibroblasts in cancer, Nat. Rev. Cancer, 16, 582, 10.1038/nrc.2016.73 Shintani, 2016, IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling, J. Thorac. Oncol., 11, 1482, 10.1016/j.jtho.2016.05.025 Tanaka, 2015, miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts, Carcinogenesis, 36, 894, 10.1093/carcin/bgv067 Ma, 2019, Cancer-associated fibroblasts promote the chemo-resistance in gastric cancer through secreting IL-11 targeting JAK/STAT3/Bcl2 pathway, Cancer Res. Treat., 51, 194, 10.4143/crt.2018.031 Wilson, 2012, Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors, Nature, 487, 505, 10.1038/nature11249 Qin, 2018, Cancer-associated fibroblast-derived IL-6 promotes head and neck cancer progression via the osteopontin-NF-kappa B signaling pathway, Theranostics, 8, 921, 10.7150/thno.22182 Borsellino, 1995, Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines, Cancer Res., 55, 4633 Chen, 2013, IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus, Mol. Cancer, 12, 26, 10.1186/1476-4598-12-26 Shimura, 2019, Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer, Oncol. Lett., 17, 5139 Mao, 2018, CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer, Cell Death Dis., 9, 763, 10.1038/s41419-018-0803-7 Qiao, 2018, IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma, Oncogene, 37, 873, 10.1038/onc.2017.387 Oka, 1996, Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma, Cancer Res., 56, 2776 Ham, 2019, Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer, Mol. Cancer, 18, 68, 10.1186/s12943-019-0972-8 Bharti, 2016, Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: a snapshot of IL-6 mediated involvement, Cancer Lett., 375, 51, 10.1016/j.canlet.2016.02.048 Wu, 2019, IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma, J. Exp. Clin. Cancer Res., 38, 321, 10.1186/s13046-019-1310-0 Osuala, 2015, Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration, BMC Cancer, 15, 584, 10.1186/s12885-015-1576-3 Goulet, 2019, Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling, BMC Cancer, 19, 137, 10.1186/s12885-019-5353-6 Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J. Natl. Cancer Inst., 92, 205, 10.1093/jnci/92.3.205